EZH2 and neoplasm: In our previous studies, we found that AQB, a small molecule drug targeting HOTAIR and EZH2, restores the expression of multiple tumor suppressor genes and inhibits EC progression, demonstrating significant antitumor activity and a favorable safety profile.